Beacon VP Capital's objective is to generate consistent returns that outperform the S&P 500. This event-driven approach to investing generates returns that are less correlated with the broader financial markets.Beacon VP Capital achieves its investment objectives by investing primarily in lesser…
Beacon VP Capital's objective is to generate consistent returns that outperform the S&P 500. This event-driven approach to investing generates returns that are less correlated with the broader financial markets.
Beacon VP Capital achieves its investment objectives by investing primarily in lesser known, micro to mid-cap biotechnology and pharmaceutical companies with pharmaceutical drugs at or near the final stage of the Food and Drug Administration (FDA) approval process. Beacon VP Capital achieves these investment objectives by pursuing an investment strategy focused on scientific analysis, proprietary research and collective intelligence.
Beacon VP Capital's science based investments consist principally of a combination of securities and derivatives issued by micro to mid-cap biotechnology and pharmaceutical companies primarily operating in the United States.
Team (1)
Sectors Beacon VP Capital serves:
Life Sciences
Join Axial's Private M&A Platform
Beacon VP Capital connects with qualified M&A advisors through the Axial Platform.
Looking for Buyers?
Reach this investor and hundreds more on Axial. No cost to advisors.
